NCT03740659View on ClinicalTrials.gov

Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

December 6, 2018

Study Completion Date

December 6, 2018

Conditions

Cataract

Interventions

DRUG

Levofloxacin + Dexamethasone

Levofloxacin + Dexamethasone ophthalmic solution + dexamethasone 21-phosphate administered twice: 90(±15) min. and 60(±15) min. before limbal paracentesis.

DRUG

Levofloxacin

Levofloxacin ophthalmic solution (Oftaquix®) administered twice: 90 (±15) min. and 60 (±15) min. before limbal paracentesis).

DRUG

Dexamethasone

Dexamethasone ophthalmic solution (Tamesad®) administered twice: 90 (±15) min. and 60 (±15) min. before Limbal paracentesis.

Trial Locations (2)

20142

ASST Santi Paolo e Carlo di Milano - P.O. San Paolo di Milano, Milan

56124

A.O.U. Pisana - P.O. di Cisanello, Pisa

All Listed Sponsors

lead

NTC srl

INDUSTRY

NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery | Biotech Hunter | Biotech Hunter